“Scientific understanding of the microbiome is rapidly growing, as is understanding of its role in human health across systems via various axes, yet few consumers…
Disclaimer: This communication is for informational purposes only, and its content is not to be construed as a promotion of the benefits of consumer-packaged goods…
Pasadena, TX (October 12, 2022) – A new study published in the peer-reviewed journal Heliyon finds that a blend of three probiotic strains from AB-Biotics,…
Multi Pronged Study Adds to Body of Evidence for Baby Colic Kaneka’s Infant Probiotic Formulation Pasadena, TX (April 19 2022) – Kaneka Probiotics has announced…
The Beneficial Gut-Brain Axis Probiotic L. plantarum DR7 is Safe and Effective Pasadena, TX (October 13, 2021) — Already known as an innovator in the…
Kaneka Receives NPN License Approval for Floradapt™ Baby Colic Newark, CA (February 9, 2020) — Kaneka Americas Holding, Inc., achieves Health Canada Class III approval…
Newark, CA (January 15, 2020) — Kaneka Americas Holding, Inc., achieves Health Canada Class III approval for Floradapt™ Cardio under the Natural Health Products Directorate…
FDA GRAS Confirms Its Safety for Use in Dietary Supplement Pasadena, TX (February 15, 2021) — Kaneka Probiotics is demonstrating its ability to innovate in…
Kaneka Americas Holding, Inc.
Probiotics Division
7979 Gateway Boulevard, Newark (CA)
94560 United States